Establishment Labs Holdings Inc., a medical technology company focused on breast aesthetics and reconstruction, announces that it has received CE marking under the European Medical Device Regulation for the Motiva Injector, the Motiva Inflatable Balloon, and the Motiva Channel Dissector.
The study, published in Lasers in Surgery and Medicine, looked at changes in scar melanin index after fractional ablative laser treatment in patients of various Fitzpatrick skin types.
A new study reveals that CO2 laser, microneedling, and nanofat can be combined for unprecedented anti-aging results and less patient downtime.
Apyx Medical Corp., the manufacturer of the proprietary Renuvion technology, announces that it has received U.S. FDA 510(k) clearance for the use of the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction.
Galderma's Sculptra has been approved by the US FDA for correcting fine lines and wrinkles in the cheek area by stimulating natural collagen production.
British scientists, in collaboration with U.S.-based biopharmaceutical startup company Neuresta, have successfully developed a novel, elongated botulinum neurotoxin that offers a potential solution for chronic pain management without the risks of paralysis or addiction.
In an urgent call-to-action, the European Society of Plastic, Reconstructive and Aesthetic Surgery has highlighted a growing concern over under-trained 'beauty surgeons' practicing without the requisite qualifications.
Cardinal Health has launched the Stray Away hair management drape, which aims to minimize hair obstruction during craniofacial and neurosurgical procedures.
Antibiotics administered before and during surgery should be discontinued immediately after a patient’s incision is closed, according to updated recommendations for preventing surgical site infections.